1998
DOI: 10.1177/095632029800900207
|View full text |Cite
|
Sign up to set email alerts
|

In VitroEvaluation and Characterization of Newly Designed Alkylamidophospholipid Analogues as Anti-Human Immunodeficiency Virus Type 1 Agents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
3
0

Year Published

2000
2000
2009
2009

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 17 publications
1
3
0
Order By: Relevance
“…All chemicals and solvents were purchased from Sigma-Aldrich and Fisher Scientific except dFdC, which was purchased from the Wake Forest University Baptist Medical Center Pharmacy. NMR data of the lipid intermediates were consistent with those previously reported. , All reactions were carried out under N 2 and extremely dry conditions. Aqueous solubility and partition coefficient measurements were tested as previously described …”
Section: Methodssupporting
confidence: 85%
See 2 more Smart Citations
“…All chemicals and solvents were purchased from Sigma-Aldrich and Fisher Scientific except dFdC, which was purchased from the Wake Forest University Baptist Medical Center Pharmacy. NMR data of the lipid intermediates were consistent with those previously reported. , All reactions were carried out under N 2 and extremely dry conditions. Aqueous solubility and partition coefficient measurements were tested as previously described …”
Section: Methodssupporting
confidence: 85%
“…NMR data of the lipid intermediates were consistent with those previously reported. 14,15 All reactions were carried out under N2 and extremely dry conditions. Aqueous solubility and partition coefficient measurements were tested as previously described.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…These drawbacks of nucleoside therapeutics provoke a profound interest in the search of prodrugs exhibiting an effectiveness superior to that of the parent drug. Among such derivatives, conjugates of nucleosides and phospholipids attracted attention and it was demonstrated that these derivatives display advantageous biological properties over free nucleosides (Ryu et al 1982;Shuto et al 1995;Vodovozova et al 1996;Herrmann et al 1997;Brachwitz et al 1998Brachwitz et al , 1999Kucera et al 1998;Mavromoustakos et al 2001;Alexander et al 2003; for a review, see Morris-Natschke et al 2003).…”
Section: Introductionmentioning
confidence: 98%